Prostate Cancer News and Research

Latest Prostate Cancer News and Research

ANGLE’s Parsortix system could help predict metastasis in prostate cancer

ANGLE plc, the specialist medtech company, is delighted to announce that researchers from the Barts Cancer Institute, Queen Mary University of London, have presented new results at the World CDx Europe 2017 conference in London of their work with ANGLE’s Parsortix system in prostate cancer.

31 Mar 2017

New analysis shows correlation between testosterone-lowering therapy for prostate cancer and dementia

A new analysis of patients who have undergone treatment for prostate cancer shows a connection between androgen deprivation therapy (ADT) - a testosterone-lowering therapy and a common treatment for the disease - and dementia, according to researchers from the Perelman School of Medicine at the University of Pennsylvania.

30 Mar 2017

Study explores new immunotherapy combinations to treat prostate cancer

Prostate cancer, notoriously resistant to immunotherapy due to its immunologically cool nature, triggers two pathways to chill an immune attack after one immunotherapy drug fires up the immune system, researchers at The University of Texas MD Anderson Cancer Center report in Nature Medicine.

29 Mar 2017

Survey finds alarming rates of shared decision making for prostate cancer screening

A new study finds that while a blood test that helps to screen for prostate cancer remains common, only 30 percent of men in a large national survey reported having a balanced discussion of the advantages and disadvantages of the screening with their doctor.

28 Mar 2017

Simple colour changing test can help speed up research for cancer drugs

A simple colour changing test to help scientists investigate potential cancer drugs has been developed by University of Bath scientists, allowing research to progress at a much greater speed than has been possible until now.

27 Mar 2017

New genetic test may give men better view on how to deal with prostate cancer risk

Scientists are reporting a test which can predict which patients are most at risk from aggressive prostate cancer, and whether they suffer an increased chance of treatment failure.

27 Mar 2017

Virtual environment education decreases anxiety before prostate cancer treatment

Radiation therapists and physicians know that education can reduce anxiety before radiation treatment but lack a standardized tool. In an effort to solve this problem, a multidisciplinary team from Jefferson College of Health Professions and Sidney Kimmel Cancer Center at Thomas Jefferson University conducted a pilot study to see if a virtual environment education program could reduce some of the anxiety their patients face.

25 Mar 2017

Researchers study risk of thrombosis and bleeding in urological surgery

The international CLUE Working Group studied the risk of thrombosis and severe haemorrhage after urological cancer operations and other forms of urological surgery.

25 Mar 2017

Random DNA copying ‘mistakes’ account for most cancer mutations, study finds

Johns Hopkins Kimmel Cancer Center scientists report data from a new study providing evidence that random, unpredictable DNA copying "mistakes" account for nearly two-thirds of the mutations that cause cancer.

24 Mar 2017

Research suggests novel strategy to target genetic anomaly in prostate cancers

New research suggests a novel strategy to target a genetic anomaly that occurs in half of all prostate cancers.

24 Mar 2017

New technology may provide non-invasive approach to diagnose and monitor prostate cancer

Technology being developed at Washington State University provides a non-invasive approach for diagnosing prostate cancer and tracking the disease's progression.

22 Mar 2017

Vanderbilt study compares side effects, outcomes of prostate cancer treatments with active surveillance

Faced with the negative quality-of-life effects from surgery and radiation treatments for prostate cancer, low risk patients may instead want to consider active surveillance with their physician, according to a study released Tuesday by the Journal of the American Medical Association

21 Mar 2017

Study sheds light on cellular mechanisms that enable prostate cancer cells to form secondary tumours

New King's College London research sheds light on the cellular mechanisms which enable cancer cells to escape the prostate and spread to other parts of the body.

20 Mar 2017

Researchers discover new genes that help prevent prostate and other cancers

New genes which help prevent prostate, skin and breast cancer development in mice have been discovered by researchers at the Wellcome Trust Sanger Institute and their collaborators.

20 Mar 2017

Compressed course of radiation treatment benefits men with localized prostate cancer, study shows

An Ontario-led international clinical trial with 1,206 men with localized prostate cancer shows that compressing radiation treatments into four weeks from eight delivers similar outcomes.

16 Mar 2017

Study uncovers genetic link to aggressive form of prostate cancer

An international study published in the Journal of the National Cancer Institute has identified a genetic connection to the aggressive form of prostate cancer.

16 Mar 2017

Dietary anti-cancer compound from broccoli may work by influence on long non-coding RNAs

Researchers have discovered one of the reasons why broccoli may be good for your health.

16 Mar 2017

Endostatin can decrease proliferation of castration-resistant prostate cancer cells

Failure of hormone deprivation therapy, which is used to slow prostate cancer in patients, leads to castration-resistant prostate cancer, a lethal form of advanced disease with limited treatment options.

10 Mar 2017

Thyroid cancer patients opting for non-intervention face challenging path, study reveals

Patients who choose not to intervene after a diagnosis of thyroid cancer face a challenging path--one that is often defined by a sense of isolation and anxiety, according to a first-of-its-kind study by researchers from The Dartmouth Institute for Health Policy and Clinical Practice and the Veteran's Administration in White River Junction, Vermont.

10 Mar 2017

Combination therapy that targets immune-busting cells effective in treating advanced prostate cancer

Advanced prostate cancer resistant to castration therapy appears to respond well to a combination of immune checkpoint blockades and treatments that target certain immune-busting cells commonly associated with poor patient prognosis and therapy resistance.

10 Mar 2017

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

ANGLE’s Parsortix system could help predict metastasis in prostate cancer

New analysis shows correlation between testosterone-lowering therapy for prostate cancer and dementia

Study explores new immunotherapy combinations to treat prostate cancer

Survey finds alarming rates of shared decision making for prostate cancer screening

Simple colour changing test can help speed up research for cancer drugs

New genetic test may give men better view on how to deal with prostate cancer risk

Virtual environment education decreases anxiety before prostate cancer treatment

Researchers study risk of thrombosis and bleeding in urological surgery

Random DNA copying ‘mistakes’ account for most cancer mutations, study finds

Research suggests novel strategy to target genetic anomaly in prostate cancers

New technology may provide non-invasive approach to diagnose and monitor prostate cancer

Vanderbilt study compares side effects, outcomes of prostate cancer treatments with active surveillance

Study sheds light on cellular mechanisms that enable prostate cancer cells to form secondary tumours

Researchers discover new genes that help prevent prostate and other cancers

Compressed course of radiation treatment benefits men with localized prostate cancer, study shows

Study uncovers genetic link to aggressive form of prostate cancer

Dietary anti-cancer compound from broccoli may work by influence on long non-coding RNAs

Endostatin can decrease proliferation of castration-resistant prostate cancer cells

Thyroid cancer patients opting for non-intervention face challenging path, study reveals

Combination therapy that targets immune-busting cells effective in treating advanced prostate cancer

What to know about prostate cancer eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in